Genset and Algene Sign Alzheimer's Study Alliance | GenomeWeb

PARIS--Genset and Algene Biotechnologies of Montreal have formed a strategic alliance for research into Alzheimer's disease. Algene has amassed a collection of clinical samples from Alzheimer's patients in Quebec and, by applying its gene mapping and statistical analysis platforms to these samples, has identified several chromosomal regions suspected to contain genes associated with the disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.